Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ingo Alberti"'
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 99:103-113
The objective was to investigate the topical iontophoretic delivery of a series of amino acid ester prodrugs of aciclovir (ACV-X, where ACV=aciclovir and X=Arg, Gly, Ile, Phe, Trp and Val) as a means to enhance cutaneous delivery of ACV. The newly sy
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 99
The objective was to determine the cutaneous biodistribution of aciclovir (ACV), that is, the amount of drug as a function of depth within the skin following topical iontophoretic administration of amino acid ester prodrugs of ACV (ACV-X, where X=Arg
Publikováno v:
Journal of Controlled Release, Vol. 71, No 3 (2001) pp. 319-27
Purpose: The objective of this study was to evaluate, using attenuated total reflectance Fourier transform infrared spectroscopy, the stratum corneum (SC) bioavailability of terbinafine (TBF) following topical treatment with four different formulatio
Publikováno v:
Pharmaceutical Research. 18:1472-1475
OBJECTIVE : The in vivo effectiveness of a topical, dermatological formulation depends on the bioa-vailability of the drug within the skin at the site of action. Unlike oral drugs, or those delivered trans-dermally for systemic effect, the amount of
Publikováno v:
Journal of Cutaneous Medicine and Surgery, Vol. 2, No 2 (1997) pp. 108-119
Background: The application of therapeutic agents to the skin addresses three general objectives: (a) the treatment of a variety of dermatologic diseases; (b) the “targeted” delivery of drugs to deeper subcutaneous tissues, with a concomitant red
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 102:19
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 50(5)
The number of drug molecules approved by the regulatory authorities for transdermal administration is relatively modest - less than two dozen. Many other therapies might benefit from the advantages offered by the transdermal route. That they have not
Autor:
Catherine Anne-Marie Curdy, Ingo Alberti, Yogeshvar N. Kalia, Richard H. Guy, Nabila Sekkat, Aarti Naik
Publikováno v:
Pharmaceutical Research. 17:1148-1150
PURPOSE : To understand and account for inter-individual variations in percutaneous drug penetration and transepidermal water loss (TEWL). METHODS: TEWL is the standard measure of stratum corneum (SC) barrier function in vivo. The use of serial tape-
Autor:
François-Xavier Mathy, Véronique Préat, Yogeshvar N. Kalia, Christophe Herkenne, Ingo Alberti, Richard H. Guy, Aarti Naik
Publikováno v:
Pharmaceutical Research, Vol. 25, no. 1, p. 87-103 (2008)
Herkenne, C, Alberti, I, Naik, A, Kalia, Y N, Mathy, F X, Préat, V & Guy, R H 2008, ' In vivo methods for the assessment of topical drug bioavailability ', Pharmaceutical Research, vol. 25, no. 1, pp. 87-103 . https://doi.org/10.1007/s11095-007-9429-7
Pharmaceutical Research
Pharmaceutical Research, Vol. 25, No 1 (2008) pp. 87-103
Herkenne, C, Alberti, I, Naik, A, Kalia, Y N, Mathy, F X, Préat, V & Guy, R H 2008, ' In vivo methods for the assessment of topical drug bioavailability ', Pharmaceutical Research, vol. 25, no. 1, pp. 87-103 . https://doi.org/10.1007/s11095-007-9429-7
Pharmaceutical Research
Pharmaceutical Research, Vol. 25, No 1 (2008) pp. 87-103
This paper reviews some current methods for the in vivo assessment of local cutaneous bioavailability in humans after topical drug application. After an introduction discussing the importance of local drug bioavailability assessment and the limitatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c82305e4e633569a11be5912170402
https://hdl.handle.net/2078.1/25817
https://hdl.handle.net/2078.1/25817
Publikováno v:
Expert opinion on drug delivery. 2(5)
Transdermal gels are designed to deliver sustained drug amounts, resulting in systemically consistent levels. They represent an improvement compared with transdermal delivery by patches because they offer more dosage flexibility, less irritation pote